Folgen
Adam J. Schwarz
Adam J. Schwarz
Head, Clinical Imaging / Takeda Pharmaceuticals
Bestätigte E-Mail-Adresse bei takeda.com
Titel
Zitiert von
Zitiert von
Jahr
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception
MW Weiner, DP Veitch, PS Aisen, LA Beckett, NJ Cairns, RC Green, ...
Alzheimer's & Dementia 9 (5), e111-e194, 2013
1288*2013
CNVs conferring risk of autism or schizophrenia affect cognition in controls
H Stefansson, A Meyer-Lindenberg, S Steinberg, B Magnusdottir, ...
Nature 505 (7483), 361-366, 2014
7102014
Regional profiles of the candidate tau PET ligand 18 F-AV-1451 recapitulate key features of Braak histopathological stages
AJ Schwarz, P Yu, BB Miller, S Shcherbinin, J Dickson, M Navitsky, ...
Brain 139 (5), 1539-1550, 2016
4732016
A stereotaxic MRI template set for the rat brain with tissue class distribution maps and co-registered anatomical atlas: application to pharmacological MRI
AJ Schwarz, A Danckaert, T Reese, A Gozzi, G Paxinos, C Watson, ...
Neuroimage 32 (2), 538-550, 2006
3902006
Quantitative imaging biomarkers: a review of statistical methods for technical performance assessment
DL Raunig, LM McShane, G Pennello, C Gatsonis, PL Carson, ...
Statistical methods in medical research 24 (1), 27-67, 2015
3412015
Test–retest reliability of evoked BOLD signals from a cognitive–emotive fMRI test battery
MM Plichta, AJ Schwarz, O Grimm, K Morgen, D Mier, L Haddad, ...
Neuroimage 60 (3), 1746-1758, 2012
3182012
copyright material
BG Blundell, AJ Schwarz
2642013
Standardization of analysis sets for reporting results from ADNI MRI data
BT Wyman, DJ Harvey, K Crawford, MA Bernstein, O Carmichael, PE Cole, ...
Alzheimer's & Dementia 9 (3), 332-337, 2013
2592013
Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer’s disease
CR Jack Jr, F Barkhof, MA Bernstein, M Cantillon, PE Cole, C DeCarli, ...
Alzheimer's & Dementia 7 (4), 474-485. e4, 2011
2512011
Negative edges and soft thresholding in complex network analysis of resting state functional connectivity data
AJ Schwarz, J McGonigle
Neuroimage 55 (3), 1132-1146, 2011
2502011
A neural switch for active and passive fear
A Gozzi, A Jain, A Giovanelli, C Bertollini, V Crestan, AJ Schwarz, ...
Neuron 67 (4), 656-666, 2010
2372010
Distributed BOLD and CBV-weighted resting-state networks in the mouse brain
F Sforazzini, AJ Schwarz, A Galbusera, A Bifone, A Gozzi
Neuroimage 87, 403-415, 2014
2292014
Large-scale functional connectivity networks in the rodent brain
A Gozzi, AJ Schwarz
Neuroimage 127, 496-509, 2016
2252016
Application of neurite orientation dispersion and density imaging (NODDI) to a tau pathology model of Alzheimer's disease
N Colgan, B Siow, JM O'Callaghan, IF Harrison, JA Wells, HE Holmes, ...
Neuroimage 125, 739-744, 2016
2182016
Functional connectivity hubs of the mouse brain
A Liska, A Galbusera, AJ Schwarz, A Gozzi
Neuroimage 115, 281-291, 2015
1922015
Alzheimer disease brain atrophy subtypes are associated with cognition and rate of decline
SL Risacher, WH Anderson, A Charil, PF Castelluccio, S Shcherbinin, ...
Neurology 89 (21), 2176-2186, 2017
1562017
The classification of volumetric display systems: characteristics and predictability of the image space
BG Blundell, AJ Schwarz
IEEE Transactions on Visualization and Computer Graphics 8 (1), 66-75, 2002
1492002
Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimer's disease
PT Trzepacz, P Yu, PK Bhamidipati, B Willis, T Forrester, L Tabas, ...
Alzheimer's & dementia 9 (5), S95-S104. e1, 2013
1422013
Amygdala habituation: a reliable fMRI phenotype
MM Plichta, O Grimm, K Morgen, D Mier, C Sauer, L Haddad, H Tost, ...
NeuroImage 103, 383-390, 2014
1412014
Differential effects of antipsychotic and glutamatergic agents on the phMRI response to phencyclidine
A Gozzi, CH Large, A Schwarz, S Bertani, V Crestan, A Bifone
Neuropsychopharmacology 33 (7), 1690-1703, 2008
1312008
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20